EMERGING TECHNOLOGY PARTNERS
Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providing superior returns to their investors. ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.
EMERGING TECHNOLOGY PARTNERS
Industry:
Angel Investment Finance Financial Services Venture Capital
Founded:
2000-01-01
Status:
Active
Contact:
301-222-2200
Email Addresses:
[email protected]
Technology used in webpage:
Google Maps OpenResty Network Solutions DNS Shockwave Flash Embed Adobe Dreamweaver Network Solutions
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-08 | Precision Autoimmune Therapeutics | Emerging Technology Partners investment in Venture Round - Precision Autoimmune Therapeutics | 140 M CNY |
| 2020-07-14 | Deep Longevity | Emerging Technology Partners investment in Series A - Deep Longevity | N/A |
| 2020-06-29 | Sun Genomics | Emerging Technology Partners investment in Series A - Sun Genomics | 9.25 M USD |
| 2020-06-24 | Polaris Biology | Emerging Technology Partners investment in Series B - Polaris Biology | 70 M CNY |
| 2020-05-01 | SleepScore Labs | Emerging Technology Partners investment in Venture Round - SleepScore Labs | N/A |
| 2019-11-07 | Human Longevity | Emerging Technology Partners investment in Series C - Human Longevity | 30 M USD |
| 2019-01-21 | Polaris Biology | Emerging Technology Partners investment in Series A - Polaris Biology | 8.25 M USD |
| 2018-12-19 | Cellestia | Emerging Technology Partners investment in Series A - Cellestia | 20 M CHF |
| 2018-03-23 | DoctorsForMe Inc | Emerging Technology Partners investment in Seed Round - DoctorsForMe Inc | 1000 K USD |
| 2017-06-01 | TCR Cure | Emerging Technology Partners investment in Series A - TCR Cure | N/A |